212 results
8-K
EX-99.1
RGEN
Repligen Corp.
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
accounts, which reflects the differentiated nature of our products in this market. We are pleased to report that for the second quarter in a row, our
8-K
EX-4.1
RGEN
Repligen Corp.
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
have knowledge of any Default under the Indenture that occurred during such fiscal year and, if so, specifying each such Default and the nature … offer or exchange offer of the nature described in Section 14.04(e);
(vii) solely for a change in the par value (or lack of par value) of the Common
8-K
EX-99.1
n58r22t7
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.2
1153xdw95bxvo pid3
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-10.1
ukd9v3nue a23na
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-10.1
awbh9vu
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
en6lptpjx9
16 Dec 21
Regulation FD Disclosure
7:11am
424B7
mxhx62p08 ud
5 Nov 21
Prospectus with selling stockholder info
4:16pm